Stocktoria
Unilever PLC ULVR.L
GB · London Stock Exchange · XLON · stock · Consumer Defensive · website
Unilever PLC financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $50.5B | $52.5B | $51.7B | $60.1B |
| Gross profit | $23.7B | $24.5B | $22.5B | $24.2B |
| R&D expense | — | $987.0M | $949.0M | $908.0M |
| SG&A expense | $13.7B | $14.3B | $13.3B | $13.6B |
| Operating income | $10.1B | $10.3B | $9.3B | $9.7B |
| Interest expense | $1.1B | $999.0M | $955.0M | $789.0M |
| Income tax | $2.5B | $2.3B | $2.0B | $2.1B |
| Net income | $9.5B | $5.7B | $6.5B | $7.6B |
| EPS (diluted) | — | $2.58 | $2.88 | $3.36 |
| Operating cash flow | $8.3B | $9.5B | $9.4B | $7.3B |
| Free cash flow | $6.8B | $7.9B | $8.0B | $5.6B |
| Cash & equivalents | $3.9B | $6.1B | $4.2B | $4.3B |
| Inventory | $4.0B | $5.2B | $5.1B | $5.9B |
| Total assets | $70.5B | $79.8B | $75.3B | $77.8B |
| Total liabilities | $52.9B | $57.2B | $54.5B | $56.1B |
| Shareholders' equity | $15.5B | $20.0B | $18.1B | $19.0B |
Growth · year-over-year · Revenue CAGR -5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -3.8% | +1.5% | -14.0% | — |
| Net income growth | +64.9% | -11.5% | -15.1% | — |
| EPS growth | — | -10.5% | -14.4% | — |
| Free cash flow growth | -14.5% | -1.1% | +43.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.